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Subacute lead perforation of the right ven-
tricle caused acute, reactive, acalculous 
cholecystis, which initially distracted the 
attention of physicians from the develop-
ment of hematopericard. Implantation 
of a cardioverter defibrillator in a young 
patient after sudden cardiac arrest, but be-
fore treatment of significant stenosis of the 
proximal left anterior descending artery, 
resulted in a life-threatening condition 
only 36 days after arrest. After removing 
the implantable cardioverter defibrillator, 
there was no sign of pathological cardiac 
rhythm disorders.
Key words: subacute lead perforation of the 
right ventricle, reactive acalculos cholecysti-
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INTRODUCTION
Sudden cardiac death (SCD) is a sud-
den, unexpected death caused by loss 
of  heart  function, and is responsible for 
half of all heart disease deaths.  SCD occurs 
most frequently in adults in their mid-30s 
to mid-40s, and affects men twice as often 
as it does women. (1) Cardiovascular dis-
eases are responsible for approximately 
17 million deaths every year in the world, 
approximately 25% of which are SCD. 
Despite all diagnostic possibilities, up to 
50% of cardiac arrests occur in individuals 
without known heart disease. (2) Preven-
tion of SCD is aimed at reduction of risk 
factors for coronary artery disease, optimal 
treatment of patients with acute coronary 
syndrome and with ischemic cardiomyo-
pathy. Recent trials have demonstrated the 
benefit of implantable cardioverter defi-
brillators (ICD).  On the other hand, ICD 
may cause complications; one of them is 
described in this case report. 
CASE PRESENTATION
A 41-year-old Caucasian man presented 
to the emergency department with a 2-day 
history of pain under the right costal arch, 
nausea, vomiting, diarrhea, hyperhidrosis 
and syncope. One month earlier, accord-
ing to his medical records, the patient had 
a cardiac arrest on the highway. The driver 
performed basic life support and called 
the emergency team, who defibrillated the 
patient with 200 J for ventricular fibrilla-
tion. The patient was then transferred to 
the nearest hospital, where therapeutic 
hypothermia was immediately initiated, 
and a work up was done to determine the 
cause of arrest. Pulmonary angiography 
with multi-slice computed tomography 
(MSCT) excluded pulmonary embolism, 
while coronary angiography revealed a 
50% stenosis of the left main coronary ar-
tery and 50%-75% stenosis of the proximal 
left anterior descending artery (LAD). As 
the patient had repetitive non-sustained 
ventricular tachycardias (nsVT), an im-
plantable cardioverter defibrillator (ICD) 
was inserted on post-arrest day 18. The day 
after, coronary angiography was repeated 
and the fractional flow reserve method 
was performed. The proximal LAD lesion 
was evaluated as significant, thus a stent 
was implanted with optimal angiographic 
result. The patient was discharged from 
the hospital on post-arrest day 30, in good 
general condition. He had felt well until 3 
days before he presented to our emergency 
department, when he experienced sudden, 
sharp pain described as if “the stent was 
scratching him”. On the day of admission, 
36 days had elapsed from cardiac arrest. 
The patient was normotensive, tachycar-
diac, eupnoic, afebrile, with normal breath 
sounds.  The abdomen was sensitive on 
palpation under the right costal arch, soft, 
with audible peristalsis. Laboratory find-
ings: L 15.5x109/L; E 3.85x1012/L; Hb 124 
g/L; D dimers 5 166 μg/L; AST 43 U/L; 
ALT 79 U/L; CRP 2.7 mg/L; troponin I 0.0 
μg/L.
Heart and lung x-ray: no signs of infiltra-
tion on lung lobes or of respiratory fail-
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ure; heart shadow enlarged, of hypertonic 
shape.
Electrocardiogram (ECG): sinus tachycar-
dia, 114/min, intermedial axis, no ST/T 
changes. 
Abdominal ultrasonography (US): a nar-
row trace of free liquid around the liver; 
thickened, inhomogeneous gallbladder 
walls, without pathologic contents within 
the gallbladder (figure 1) and minor pleu-
ral effusion on the left. 
The patient was hospitalized under the di-
agnosis of acute acalculous cholecystitis. 
The next morning  a repeat abdominal US 
still revealed signs of cholecystitis, with 
bilateral pleural and pericardial effusions. 
Echocardiography showed heart cavities 
of normal dimensions, hypertrophy of the 
interventricular septum, which was dis-
cretely hypokinetic, pericardial effusion 
at 8 mm before the right ventricle and 17 
mm behind the posterior wall of the left 
ventricle and a left ventricle ejection frac-
tion (EF LV) of 45%-50%. The ICD elec-
trode passed through the right atrium and 
right ventricle, with the tip of the electrode 
passing through the right ventricular wall 
and ending up in the pericardial effusion 
(figure 2).
The exact site of the electrode tip could 
not be visualized with certainty on MSCT 
of the thorax, due to reverberations of the 
metal part of the lead (figure 3).
The patient was transferred to the cardiac 
surgery department, where thoracotomy 
was performed and 200 mL of sanguinate 
pericardial effusion was removed after 
opening the pericardium. The right ven-
tricle was perforated by the ICD lead, but 
there was no hemorrhage at the site of the 
rupture, with the lead in its position. A 
minor hematoma was found and evacu-
ated. Upon extraction of the ICD lead, ac-
tive hemorrhage was observed at the site 
of perforation, which was closed with two 
sutures. The ICD lead and the battery were 
removed. Before discharge from hospital, 
the patient underwent a 8.5 minutes exer-
cise test at oxygen consumption of 34.65 
mL/kg/min, metabolic equivalents of task 
(METs) 9.9 and 79% theoretical maxi-
mum; without malignant arrhythmias and 
clinical or ECG findings of coronary insuf-
ficiency.
During cardiac rehabilitation, the patient 
had no complaints. Noninvasive tests 
showed no malignant ventricular arrhyth-
mia or coronary insufficiency.
DISCUSSION
 
Lead perforation is a rare complication 
of ICD, the incidence ranging from 0.6% 
to 5.2%. (3) Ventricular perforations are 
divided into acute (within 24 h of place-
ment), subacute (5-29 days after place-
ment), and delayed (more than 30 days 
after placement). (4) Subacute and delayed 
perforations are rare and often not recog-
nized. Acalculous cholecystitis occurs in 
10% of all cases, usually associated with 
more serious morbidity and higher mor-
tality rates, and traditionally observed in 
critically ill patients. (5)  But, it has also 
been reported in outpatients without typi-
cal predisposing critical illness. (6) In spite 
of these reports, we believe that in the case 
of acute acalculous cholecystitis, physi-
cians should always take into account the 
possibility of an underlying serious con-
dition. Namely, the clinical condition of 
our patient was not seriously disturbed 
and hence the diagnosis of “only” acute 
acalculous cholecystitis was made, which 
easily distracted the physician from more 
serious medical conditions. Appropriate 
management of the mechanical irritation 
and hematopericardium led to complete 
regression of the inflammatory lesions of 
the gallbladder. Diagnosis of both condi-
tions was performed by ultrasound, while 
multi slice computer tomography was in-
ferior because of reverberation of the for-
eign body. Subacute and/or late perfora-
tion of the right ventricle can be corrected 
by thoracotomy, in particular if the lead 
is in the mediastinum or other surround-
ing structures, with signs of hemorrhage; 
in some patients, it can be removed under 
fluoroscope or transesophageal US guid-
ance, however, with a surgical team being 
ready to intervene. (7) In order to mini-
mize the possibility of heart perforation, 
the lead should always be positioned along 
the septal wall or in the region of the right 
ventricle outflow tract. The most impor-
tant point is that indication for all invasive 
procedures, as well as for ICD placement, 
should be carefully weighed. In the case 
presented, initial management of the sig-
nificant proximal LAD stenosis followed by 
the decision for ICD implantation should 
have been optimal planning of therapeu-
tic algorithm, especially considering the 
necessary balancing the benefits, possible 
complications and cost of a therapeutic 
procedure. After the ICD was removed, 
the patient had no malignant disorders 
of cardiac rhythm or signs of myocardial 
ischemia, which confirms our belief that 
after solving the critical LAD stenosis, 
implantation of an ICD was superfluous. 
Only 36 days after arrest, the patient’s life 
was jeopardized again because of perform-
ing an “overprotective” procedure. 
Figure 1. Acalculous cholecystitis.  Figure 2.  The intracardial defibrillator 
electrode seen outside the wall of the right 
ventricle. 
Figure 3. Multislice computed tomogra-
phy of the thorax: reverberation of the 
intracardial defibrillator lead, excluded 
the possibility of accurately determining its 
position.
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